MIRMMirum Pharmaceuticals, Inc.
$80.36+8.0% 1Y
$80.36
$64.1052 weeks$128.58
Is the price fair?
What MIRM's price assumes
Mirum Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 8.44× revenue.
8.44
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 8.95
EV / sales
Details›
- EV / EBIToperating margin −135%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 8.95
- Market capitalisation64.9 million shares, counted Jul 31, 2026
- $5.22B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks